Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland, USA.
Department of Family Medicine, University of Washington, Seattle, Washington, USA.
Colorectal Dis. 2022 Nov;24(11):1344-1351. doi: 10.1111/codi.16232. Epub 2022 Jul 11.
International studies have shown that most colon cancers are diagnosed among people with symptoms, but research is limited in the United States. Here, we conducted a retrospective study of adults aged 50-85 years diagnosed with stage I-IIIA colon cancer between 1995 and 2014 in two US healthcare systems.
Mode of detection (screening or symptomatic) was ascertained from medical records. We estimated unadjusted odds ratios (OR) and 95% confidence intervals (CI) comparing detection mode by patient factors at diagnosis (year, age, sex, race, smoking status, body mass index [BMI], Charlson score), prediagnostic primary care utilization, and tumour characteristics (stage, location).
Of 1,675 people with colon cancer, 38.4% were screen-detected, while 61.6% were diagnosed following symptomatic presentation. Screen-detected cancer was more common among those diagnosed between 2010 and 2014 versus 1995-1999 (OR 1.65, 95% CI: 1.19-2.28), and those with a BMI of 25-<30 kg/m (OR 1.54, 95% CI: 1.21-1.98) or ≥30 kg/m (OR 1.52, 95% CI: 1.18-1.96) versus <25 kg/m . Screen-detected cancer was less common among people aged 76-85 (OR 0.50, 95% CI: 0.39-0.65) versus 50-64, those with comorbidity scores >0 (OR 0.71, 95% CI: 0.56-0.91 for score = 1, OR 0.34, 95% CI: 0.26-0.45 for score = 2+), and those with 2+ prediagnostic primary care visits (OR 0.53, 95% CI: 0.37-0.76) versus 0 visits. The odds of screen detection were lower among patients diagnosed with stage IIA (OR 0.33, 95% CI = 0.27-0.41) or IIB (OR 0.12, 95% CI: 0.06-0.24) cancers versus stage I.
Most colon cancers among screen-eligible adults were diagnosed following symptomatic presentation. Even with increasing screening rates over time, research is needed to better understand why specific groups are more likely to be diagnosed when symptomatic and identify opportunities for interventions.
国际研究表明,大多数结肠癌是在有症状的人群中诊断出来的,但美国的研究有限。在这里,我们对 1995 年至 2014 年间在两个美国医疗保健系统中诊断为 I 期-IIIa 期结肠癌的 50-85 岁成年人进行了回顾性研究。
通过病历确定检测方式(筛查或症状)。我们根据患者在诊断时的因素(年份、年龄、性别、种族、吸烟状况、体重指数[BMI]、Charlson 评分)、诊断前初级保健的使用情况以及肿瘤特征(分期、位置),比较了不同检测模式的未调整比值比(OR)和 95%置信区间(CI)。
在 1675 名结肠癌患者中,38.4%为筛查检出,61.6%为症状出现后检出。与 1995-1999 年相比,2010-2014 年诊断的癌症更常见于筛查检出(OR 1.65,95%CI:1.19-2.28),BMI 为 25-<30kg/m(OR 1.54,95%CI:1.21-1.98)或≥30kg/m(OR 1.52,95%CI:1.18-1.96)的人群较 BMI<25kg/m 者更常见。76-85 岁人群的筛查检出率较低(OR 0.50,95%CI:0.39-0.65),50-64 岁人群的筛查检出率较高;合并症评分>0(OR 0.71,95%CI:0.56-0.91,评分=1;OR 0.34,95%CI:0.26-0.45,评分=2+)的人群筛查检出率较低;诊断前初级保健就诊次数为 2+次(OR 0.53,95%CI:0.37-0.76)的人群筛查检出率较低,0 次就诊者的筛查检出率较高。与 I 期癌症相比,IIA(OR 0.33,95%CI=0.27-0.41)或 IIB(OR 0.12,95%CI:0.06-0.24)期癌症患者的筛查检出率较低。
大多数符合筛查条件的成年人的结肠癌是在出现症状后诊断出来的。尽管随着时间的推移筛查率有所增加,但仍需要研究以更好地了解为什么某些群体更有可能在出现症状时被诊断出癌症,并确定干预的机会。